Recent advances in antibody-inducing poxviral and adenoviral vectored vaccine delivery platforms for difficult disease targets.

Recent advances in antibody-inducing poxviral and adenoviral vectored vaccine delivery platforms for difficult disease targets.

Viral vectored vaccine delivery platforms have traditionally been used for the induction of cellular rather than humoral immunity. However, in recent years, recombinant adenoviral and poxviral vectored vaccines have been optimized to induce B-cell responses, resulting in the demonstration of high-ti...

Descripció completa

Dades bibliogràfiques
Autors principals:	de Cassan, S, Draper, S
Format:	Journal article
Idioma:	English
Publicat:	2013

Ítems similars

Utilizing poxviral vectored vaccines for antibody induction-progress and prospects.
per: Draper, S, et al.
Publicat: (2013)

Long-term thermostabilization of live poxviral and adenoviral vaccine vectors at supraphysiological temperatures in carbohydrate glass.
per: Alcock, R, et al.
Publicat: (2010)

Distinct patterns of whole blood transcriptional responses are induced in mice following immunisation with adenoviral and poxviral vector vaccines encoding the same antigen
per: Sheerin, D, et al.
Publicat: (2021)

New candidate vaccines against blood-stage Plasmodium falciparum malaria: prime-boost immunization regimens incorporating human and simian adenoviral vectors and poxviral vectors expressing an optimized antigen based on merozoite surface protein 1.
per: Goodman, A, et al.
Publicat: (2010)

Poxviral Targeting of Interferon Regulatory Factor Activation
per: Clara Lawler, et al.
Publicat: (2020-10-01)

Poxviral Ankyrin Proteins
per: Michael H. Herbert, et al.
Publicat: (2015-02-01)

Adenoviral Vector-Based Vaccine Platforms for Developing the Next Generation of Influenza Vaccines
per: Ekramy E. Sayedahmed, et al.
Publicat: (2020-10-01)

Adenoviral vector vaccine platforms in the SARS-CoV-2 pandemic
per: Samir Andrade Mendonça, et al.
Publicat: (2021-08-01)

Adenoviral Vector-Based Vaccine Platform for COVID-19: Current Status
per: Vivek P. Chavda, et al.
Publicat: (2023-02-01)

Poxviral promoters for improving the immunogenicity of MVA delivered vaccines
per: Naif Khalaf Alharbi
Publicat: (2019-01-01)

Methods of treating Poxviral Infections
per: Ramstedt, U, et al.
Publicat: (2011)

New Candidate Vaccines against Blood-Stage Plasmodium falciparum Malaria: Prime-Boost Immunization Regimens Incorporating Human and Simian Adenoviral Vectors and Poxviral Vectors Expressing an Optimized Antigen Based on Merozoite Surface Protein 1, (vol 78, pg 4610, 2010)
per: Goodman, A, et al.
Publicat: (2011)

Adenoviral vectors as novel vaccines for influenza.
per: Coughlan, L, et al.
Publicat: (2015)

Development of novel vaccine vectors: Chimpanzee adenoviral vectors
per: Jingao Guo, et al.
Publicat: (2018-07-01)

T cell responses induced by adenoviral vectored vaccines can be adjuvanted by fusion of antigen to the oligomerization domain of C4b-binding protein.
per: Forbes, E, et al.
Publicat: (2012)

Chimpanzee adenoviral vectors as vaccines for outbreak pathogens
per: Ewer (nee Russell), K, et al.
Publicat: (2017)

Chimpanzee adenoviral vectors as vaccines for outbreak pathogens
per: Katie Ewer, et al.
Publicat: (2017-12-01)

Using multivalent adenoviral vectors for HIV vaccination.
per: Linlin Gu, et al.
Publicat: (2013-01-01)

Nonhuman Adenoviral Vector-Based Platforms and Their Utility in Designing Next Generation of Vaccines for Infectious Diseases
per: Marwa Alhashimi, et al.
Publicat: (2021-07-01)

mRNA and Adenoviral Vector Vaccine Platforms Utilized in COVID-19 Vaccines: Technologies, Ecosystem, and Future Directions
per: Ryo Okuyama
Publicat: (2023-11-01)

Pandemic-response adenoviral vector and RNA vaccine manufacturing
per: Zoltán Kis, et al.
Publicat: (2022-03-01)

The use of adenoviral vectors in gene therapy and vaccine approaches
per: Natália Meneses Araújo, et al.
Publicat: (2022-10-01)

Poxviral Strategies to Overcome Host Cell Apoptosis
per: Chathura D. Suraweera, et al.
Publicat: (2020-12-01)

Subretinal gene delivery using helper-dependent adenoviral vectors
per: Wu Linda, et al.
Publicat: (2011-04-01)

Advances of Recombinant Adenoviral Vectors in Preclinical and Clinical Applications
per: Luca Scarsella, et al.
Publicat: (2024-02-01)

In vitro evaluation of a 'stealth' adenoviral vector for targeted gene delivery to adult mammalian neurones.
per: Sims, K, et al.
Publicat: (2009)

In vitro immune evaluation of adenoviral vector-based platform for infectious diseases
per: Joanna Baran, et al.
Publicat: (2023-12-01)

T cell responses induced by adenoviral vectored vaccines can be adjuvanted by fusion of antigen to the oligomerization domain of C4b-binding protein.
per: Emily K Forbes, et al.
Publicat: (2012-01-01)

Differential Biodistribution of Adenoviral-Vectored Vaccine Following Intranasal and Endotracheal Deliveries Leads to Different Immune Outcomes
per: Vidthiya Jeyanathan, et al.
Publicat: (2022-06-01)

Advances and Future Challenges in Recombinant Adenoviral Vectored H5N1 Influenza Vaccines
per: Jianfeng Zhang
Publicat: (2012-11-01)

Updates and New Perspectives on Adenoviral Gene Therapy and Vaccine Vectors
per: Thomas Dobner, et al.
Publicat: (2023-02-01)

STING-pathway modulation to enhance the immunogenicity of adenoviral-vectored vaccines
per: Eriko Padron-Regalado, et al.
Publicat: (2022-08-01)

An Adenoviral Vector as a Versatile Tool for Delivery and Expression of miRNAs
per: Jonas Scholz, et al.
Publicat: (2022-09-01)

Nodular Dermatitis: Emergence of Novel Poxviral Infection in Russia
per: S. V. Borisevich, et al.
Publicat: (2018-04-01)

IN VIVO ANTIGENIC TARGETS OF T CELLS INDUCED BY ADENOVIRAL VECTORED VACCINES IN PATIENTS WITH CHRONIC HCV INFECTION
per: Kelly, C, et al.
Publicat: (2012)

Synergism/complementarity of recombinant adenoviral vectors and other vaccination platforms during induction of protective immunity against malaria
per: Ana Paula Morais Martins Almeida, et al.
Publicat: (2011-08-01)

Adenoviral vectors for gene therapy /
per: Curiel, David T., et al.
Publicat: (2002)

Construction and application of adenoviral vectors
per: Hongbo Zhang, et al.
Publicat: (2023-12-01)

EVALUATION OF SIMIAN ADENOVIRAL VECTOR ADCH63 EXPRESSING MSP-1 AS A CANDIDATE BLOOD-STAGE MALARIA VACCINE
per: Goodman, A, et al.
Publicat: (2009)

Oral vaccination of mice with adenoviral vectors is not impaired by preexisting immunity to the vaccine carrier.
per: Xiang, Z, et al.
Publicat: (2003)